Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Postpartum Rh immunoprophylaxis.

Sandler SG, Gottschall JL.

Obstet Gynecol. 2012 Dec;120(6):1428-38. doi: http://10.1097/AOG.0b013e3182742eba. Review.

PMID:
23168770
2.

Laboratory methods for Rh immunoprophylaxis: a review.

Sandler SG, Sathiyamoorthy S.

Immunohematology. 2010;26(3):92-103. Review.

PMID:
21214295
3.

Detection of fetomaternal hemorrhage.

Kim YA, Makar RS.

Am J Hematol. 2012 Apr;87(4):417-23. doi: 10.1002/ajh.22255. Review.

4.

[Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].

Cortey A, Brossard Y.

J Gynecol Obstet Biol Reprod (Paris). 2006 Feb;35(1 Suppl):1S123-1S130. Review. French.

5.

The scientific basis of antenatal prophylaxis.

Urbaniak SJ.

Br J Obstet Gynaecol. 1998 Nov;105 Suppl 18:11-8. Review.

PMID:
9863973
6.

[Calculation of feto-maternal haemorrhage volume using various morphological parameters and various formulas].

Gielezynska A, Fabijańska-Mitek J, Debska M.

Pol Merkur Lekarski. 2011 Mar;30(177):228-30. Review. Polish.

PMID:
21545004
7.

Do Rh-negative women with first trimester spontaneous abortions need Rh immune globulin?

Hannafin B, Lovecchio F, Blackburn P.

Am J Emerg Med. 2006 Jul;24(4):487-9. Review.

PMID:
16787810
8.

[Prevention of fetomaternal rhesus-D allo-immunization. Perspectives].

Cortey A, Brossard Y, Beliard R, Bourel D.

J Gynecol Obstet Biol Reprod (Paris). 2006 Feb;35(1 Suppl):1S119-1S122. Review. French.

9.

Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists.

Hartwell EA.

Am J Clin Pathol. 1998 Sep;110(3):281-92. Review.

PMID:
9728602
10.

Rh Immunoprophylaxis for Women With a Serologic Weak D Phenotype.

Virk M, Sandler SG.

Lab Med. 2015 Summer;46(3):190-4. doi: 10.1309/LMUNUP4FJTUX2GCD. Review.

PMID:
26199257
11.

[Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].

Mannessier L, Alie-Daram S, Roubinet F, Valat AS, Depoortère MH, Fournié A, Puech F.

J Gynecol Obstet Biol Reprod (Paris). 2000 Sep;29(5):441-4. Review. French. No abstract available.

12.

Is Rh immune globulin needed in early first-trimester abortion? A review.

Jabara S, Barnhart KT.

Am J Obstet Gynecol. 2003 Mar;188(3):623-7. Review.

PMID:
12634631
13.

[Epidemiology of anti-D allo-immunization during pregnancy].

Branger B, Winer N.

J Gynecol Obstet Biol Reprod (Paris). 2006 Feb;35(1 Suppl):1S87-1S92. Review. French.

14.

[Prevention of Rh immunization. II. Management of the risk during the second half of pregnancy and postpartum].

Larsen JF, Bock JE, Jørgensen JR.

Ugeskr Laeger. 2004 Aug 30;166(36):3078-83. Review. Danish. No abstract available.

PMID:
15387304
15.

Prevention of RhD alloimmunization in RhD negative women.

Lubusky M.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010 Mar;154(1):3-7. Review.

16.

The use of Rh immune globulin: a review.

Sutton GP, Jay A, Lim YS, Noland JE Jr, Boral LI.

Indiana Med. 1988 Apr;81(4):321-2. Review. No abstract available.

PMID:
2834434
17.

Prevention and management of RhD isoimmunization.

Harkness UF, Spinnato JA.

Clin Perinatol. 2004 Dec;31(4):721-42, vi. Review.

PMID:
15519425
18.

The prevention of Rh haemolytic disease of the fetus and newborn--general background.

Contreras M.

Br J Obstet Gynaecol. 1998 Nov;105 Suppl 18:7-10. Review. No abstract available.

PMID:
9863972
19.

[Adverse effects and patient information].

Cortey A, Brossard Y.

J Gynecol Obstet Biol Reprod (Paris). 2006 Feb;35(1 Suppl):1S112-1S118. Review. French.

20.

RHD genotyping from maternal plasma: guidelines and technical challenges.

Avent ND.

Methods Mol Biol. 2008;444:185-201. doi: 10.1007/978-1-59745-066-9_14. Review.

PMID:
18425481
Items per page

Supplemental Content

Support Center